Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BILL | Common Stock | Options Exercise | $78.9K | +15K | +14.35% | $5.26* | 120K | Jun 15, 2023 | Direct | |
transaction | BILL | Common Stock | Sale | -$261K | -2.32K | -1.94% | $112.44 | 117K | Jun 15, 2023 | Direct | F1, F2 |
transaction | BILL | Common Stock | Sale | -$193K | -1.7K | -1.45% | $113.34 | 116K | Jun 15, 2023 | Direct | F1, F3 |
transaction | BILL | Common Stock | Sale | -$1.6M | -14K | -12.08% | $114.54 | 102K | Jun 15, 2023 | Direct | F1, F4 |
transaction | BILL | Common Stock | Sale | -$1.69M | -14.7K | -14.45% | $115.18 | 86.9K | Jun 15, 2023 | Direct | F1, F5 |
holding | BILL | Common Stock | 1.71M | Jun 15, 2023 | See Footnote | F6 | |||||
holding | BILL | Common Stock | 135K | Jun 15, 2023 | See Footnote | F7 | |||||
holding | BILL | Common Stock | 135K | Jun 15, 2023 | See Footnote | F7 | |||||
holding | BILL | Common Stock | 163K | Jun 15, 2023 | See Footnote | F8 | |||||
holding | BILL | Common Stock | 163K | Jun 15, 2023 | See Footnote | F9 | |||||
holding | BILL | Common Stock | 205K | Jun 15, 2023 | See Footnote | F10 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BILL | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -15K | -7.27% | $0.00 | 191K | Jun 15, 2023 | Common Stock | 15K | $5.26 | Direct | F11 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. |
F2 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.81 to $112.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.92 to $113.85 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F4 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.94 to $114.93 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F5 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.94 to $115.61 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F6 | The shares are held by Chung Lacerte Trust U/A dated February 15, 2004, Rene A. Lacerte and Joyce A. Chung, Trustees. |
F7 | The shares are held by a family trust with Rene A. Lacerte and Joyce A. Chung, as Trustors, and Rene A. Lacerte, Joyce A. Chung, and Daniel C. Chung, as Trustees. |
F8 | The shares are held by Ilio Irrevocable Trust, Rene Lacerte and Joyce Chung, Trustees. |
F9 | The shares are held by Nene Irrevocable Trust, Rene Lacerte and Joyce Chung, Trustees. |
F10 | The shares are held by the Makahakama Foundation. |
F11 | The option vests 1/48th of the total shares monthly beginning September 2, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. |